Navigation Links
ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
Date:5/19/2008

SAN MARINO, Calif., May 19 /PRNewswire/ -- Epeius Biotechnologies announced today the results of an on-going Phase I/II study of Rexin-G for metastatic pancreatic cancer (Chawla et al., ASCO meeting, 2008). Continuing on with the planned dose-escalations of Rexin-G which began in 2005 using lower doses of Rexin-G in a Phase I safety study (Molecular Therapy, 2008), the current Phase I/II study employed higher dose-escalations of Rexin-G given i.v. two to three times a week for 4 weeks, beginning with 8 x 10e11 cfu to 6 x 10e12 cfu with a goal to safely reach the point where the clinical anti-tumor activity of Rexin-G would be clearly and unequivocally demonstrated.

*(LOGO: Send2Press.com/mediaboom/08-0421-Epeius_72dpi.jpg)

The results of this latest Phase I/II study of targeted gene delivery in vivo are very encouraging -- intravenous infusions of Rexin-G demonstrated significant biological activity without toxicity in patients with progressive chemo-resistant pancreatic cancer. Once the overall safety record of repeated infusions of Rexin-G was clearly demonstrated, the FDA approved across the board intra-patient dose-escalations (an adaptive design) to gain better tumor control. These higher doses of Rexin-G were associated with stabilization of disease, using both RECIST and International PET criteria, significant reductions in CA 19.9 levels, and an increase in median overall survival (greater than 6 months) which was twice that observed in the low-dose safety study. No dose-limiting toxicity was observed, even at these higher doses of Rexin-G, thus confirming that repeated infusions of Rexin-G are safe and well-tolerated.

The importance of these progressive dose-escalation studies -- which clearly establish safety before escalating to more potent tumoricidal levels -- is of primary concern in the development of a new genetic medicine like Rexin-G. Moreover, the establishment of a functional dose-response relationship is also of funda
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Commencement 2008: Student innovation could improve data storage, magnetic sensors
2. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
3. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. The World Economic Forum Announces Technology Pioneers 2008: Mondobiotech Selected
5. Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
6. ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
7. Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiologys Toughest Questions
8. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
9. USGI Medical Demonstrates First System for Gastrotomy Closure in NOTES
10. Job-related stress: NIST demonstrates fatigue effects in silicon
11. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... IL (PRWEB) May 23, 2013 Bed bugs ... against the pests is still ongoing, a report from kmov.com ... more for the bed bug treatment. Meanwhile, to be of ... apartment from the costly bed bug exterminator service. ... stated that AHA has so far spent $35,000 ...
(Date:5/23/2013)... Just released this month on Amazon and B&N is ... “Commit to Confidence: 30 Strategies to Help Women Step ... quotes from the fields of psychology and business, relevant and ... can do on their own or with a coach, this ... goals. , “My book is a five-chapter coaching ...
(Date:5/22/2013)... Cambridge Semantics was one of just ... Day” on Capitol Hill, hosted by The Data ... others to showcase how innovative data management applications can address ... (DATA Act). , Originally introduced in 2011 by Committee ... Mark Warner (D-VA ), the DATA Act is ...
(Date:5/22/2013)...  Superior Controls, Inc. has been named "Manufacturing/Technology ... Magazine.  For the past 22 years, the magazine ... with extraordinary business and civic excellence. ... said Rick Pierro , President ... award is a reflection of Superior Controls, continuing ...
Breaking Biology Technology:Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Global Nucleic Acid Testing Industry , ... http://www.reportlinker.com/p0209257/Global-Nucleic-Acid-Testing-Industry.html , , , ... for Nucleic Acid Testing in US$ Million. Annual estimates and forecasts are provided for the ...
... , , ... , , ... /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that ... of the Company,s lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) ...
... address biotechnology, science, policy and ethical issues , ... WASHINGTON , June 22 ... Drug Administration outlined a "path " to accelerate and help ensure ... genetic make-up.  Significant progress in this rapidly developing field will hinge on ...
Cached Biology Technology:Reportlinker Adds Global Nucleic Acid Testing Industry 2Reportlinker Adds Global Nucleic Acid Testing Industry 3Reportlinker Adds Global Nucleic Acid Testing Industry 4Reportlinker Adds Global Nucleic Acid Testing Industry 5Reportlinker Adds Global Nucleic Acid Testing Industry 6Reportlinker Adds Global Nucleic Acid Testing Industry 7Reportlinker Adds Global Nucleic Acid Testing Industry 8Reportlinker Adds Global Nucleic Acid Testing Industry 9Reportlinker Adds Global Nucleic Acid Testing Industry 10Resverlogix Scientific Data Presented at EAS Congress 2Resverlogix Scientific Data Presented at EAS Congress 3Resverlogix Scientific Data Presented at EAS Congress 4Pebbles Along the 'Path' to Personalized Medicine 2Pebbles Along the 'Path' to Personalized Medicine 3Pebbles Along the 'Path' to Personalized Medicine 4
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Common food supplement fights degenerative brain disorders 2
... in Botswana, Harvard School of Public Health researchers have ... settings, who receive antiretroviral (ARV) therapy, can achieve comparable ... supported health care delivery system and infrastructure help ensure ... issue of the Journal of Acquired Immune Deficiency Syndromes ...
... in Botswana, Harvard School of Public Health researchers have ... settings, who receive antiretroviral (ARV) therapy, can achieve comparable ... supported health care delivery system and infrastructure help ensure ... issue of the Journal of Acquired Immune Deficiency Syndromes ...
... results from a study in Botswana, Harvard School of ... subtype C in resource-poor settings, who receive antiretroviral (ARV) ... developed world. A fully supported health care delivery system ... published in November 2005 issue of the Journal of ...
Cached Biology News:Largest computational biology simulation mimics life’s most essential nanomachine 2New Therapeutic Target Identified In Inherited Brain Tumor Disorder 2HIV-infected adults in Botswana respond positively to ARV therapy public treatment program 2
Designed for flow cytometric applications intended to identify...
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins...
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
MOUSE ANTI RABBIT T LYMPHOCTYES Immunogen: Rabbit Thymocytes...
Biology Products: